Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Soderakra Cardiovascular Risk Factor Study

Petersson, U. ; Oestgren, C. J. ; Brudin, L. ; Brismar, K. and Nilsson, Peter LU (2009) In Diabetes & Metabolism 35(3). p.198-205
Abstract
Aim. - To explore the association between baseline levels of insulin-like growth-factor-binding protein-1 (IGFBP-1), a marker of insulin sensitivity, and the development of type 2 diabetes or impaired glucose tolerance (IGT) in a specifically defined middle-aged population. Methods. - This cross-sectional population-based screening study was conducted in 1989-1990 and included baseline data for 664 non-diabetic subjects aged 40-59 years. Clinical data were collected and blood samples analyzed for blood glucose, serum lipids and insulin. Blood specimens were frozen at baseline and later analyzed for IGF-I, IGFBP-1 and C-reactive protein (CRP). At the follow-up in 2006, the incidence of type 2 diabetes and IGT was reported based on... (More)
Aim. - To explore the association between baseline levels of insulin-like growth-factor-binding protein-1 (IGFBP-1), a marker of insulin sensitivity, and the development of type 2 diabetes or impaired glucose tolerance (IGT) in a specifically defined middle-aged population. Methods. - This cross-sectional population-based screening study was conducted in 1989-1990 and included baseline data for 664 non-diabetic subjects aged 40-59 years. Clinical data were collected and blood samples analyzed for blood glucose, serum lipids and insulin. Blood specimens were frozen at baseline and later analyzed for IGF-I, IGFBP-1 and C-reactive protein (CRP). At the follow-up in 2006, the incidence of type 2 diabetes and IGT was reported based on primary-care medical records. Results. - During the 17-year observation period, 42 subjects (6.3%) developed type 2 diabetes/IGT. Those in the lowest quintile of IGFBP-1 (<= 24 mu g/L) at baseline had a diabetes incidence of 12.6% while, in the highest quintile of IGFBP-1 (>= 59 mu g/L), the incidence was 1.5%. Cox's proportional-hazards model regression analyses were used to determine the incidence of type 2 diabetes/IGT, corrected for age and gender, in relation to IGFBP-1, CRP and waist circumference. Subjects in the lowest IGFBP-1 quintile showed an independently increased risk of type 2 diabetes/IGT [hazards ratio (HR): 3.54; 95% Cl 1.18-10.6; P = 0.024]. For CRP and waist circumference, the corresponding figures were HR: 6.81; 95% Cl 2.50-18.6; P < 0.001 and HR: 3.33; 95% Cl 1.47-7.6; P = 0.004, respectively. Conclusion. - Low levels of IGFBP-1 predicted the long-term development of type 2 diabetes or IGT in a middle-aged population. The association was independent of CRP and abdominal obesity. (C) 2009 Elsevier Masson SAS. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Longitudinal study, Type 2 diabetes, Screening, Prediction, CRP, IGFBP-1
in
Diabetes & Metabolism
volume
35
issue
3
pages
198 - 205
publisher
Elsevier Masson SAS
external identifiers
  • wos:000267655700006
  • scopus:67349108377
ISSN
1878-1780
DOI
10.1016/j.diabet.2008.11.003
language
English
LU publication?
yes
id
5b7ac6c9-a387-48b4-9a8e-1d56a1b5c2bb (old id 1463321)
date added to LUP
2016-04-01 14:10:25
date last changed
2022-04-22 01:45:06
@article{5b7ac6c9-a387-48b4-9a8e-1d56a1b5c2bb,
  abstract     = {{Aim. - To explore the association between baseline levels of insulin-like growth-factor-binding protein-1 (IGFBP-1), a marker of insulin sensitivity, and the development of type 2 diabetes or impaired glucose tolerance (IGT) in a specifically defined middle-aged population. Methods. - This cross-sectional population-based screening study was conducted in 1989-1990 and included baseline data for 664 non-diabetic subjects aged 40-59 years. Clinical data were collected and blood samples analyzed for blood glucose, serum lipids and insulin. Blood specimens were frozen at baseline and later analyzed for IGF-I, IGFBP-1 and C-reactive protein (CRP). At the follow-up in 2006, the incidence of type 2 diabetes and IGT was reported based on primary-care medical records. Results. - During the 17-year observation period, 42 subjects (6.3%) developed type 2 diabetes/IGT. Those in the lowest quintile of IGFBP-1 (&lt;= 24 mu g/L) at baseline had a diabetes incidence of 12.6% while, in the highest quintile of IGFBP-1 (&gt;= 59 mu g/L), the incidence was 1.5%. Cox's proportional-hazards model regression analyses were used to determine the incidence of type 2 diabetes/IGT, corrected for age and gender, in relation to IGFBP-1, CRP and waist circumference. Subjects in the lowest IGFBP-1 quintile showed an independently increased risk of type 2 diabetes/IGT [hazards ratio (HR): 3.54; 95% Cl 1.18-10.6; P = 0.024]. For CRP and waist circumference, the corresponding figures were HR: 6.81; 95% Cl 2.50-18.6; P &lt; 0.001 and HR: 3.33; 95% Cl 1.47-7.6; P = 0.004, respectively. Conclusion. - Low levels of IGFBP-1 predicted the long-term development of type 2 diabetes or IGT in a middle-aged population. The association was independent of CRP and abdominal obesity. (C) 2009 Elsevier Masson SAS. All rights reserved.}},
  author       = {{Petersson, U. and Oestgren, C. J. and Brudin, L. and Brismar, K. and Nilsson, Peter}},
  issn         = {{1878-1780}},
  keywords     = {{Longitudinal study; Type 2 diabetes; Screening; Prediction; CRP; IGFBP-1}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{198--205}},
  publisher    = {{Elsevier Masson SAS}},
  series       = {{Diabetes & Metabolism}},
  title        = {{Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Soderakra Cardiovascular Risk Factor Study}},
  url          = {{http://dx.doi.org/10.1016/j.diabet.2008.11.003}},
  doi          = {{10.1016/j.diabet.2008.11.003}},
  volume       = {{35}},
  year         = {{2009}},
}